P.A.W. Capital Corp reduced its stake in Radcom Ltd. (NASDAQ:RDCM - Free Report) by 14.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 150,000 shares of the technology company's stock after selling 25,000 shares during the period. Radcom accounts for approximately 4.2% of P.A.W. Capital Corp's investment portfolio, making the stock its 9th biggest position. P.A.W. Capital Corp owned approximately 0.96% of Radcom worth $1,714,000 as of its most recent SEC filing.
Other large investors also recently modified their holdings of the company. Public Employees Retirement System of Ohio acquired a new stake in Radcom during the 4th quarter worth approximately $31,000. JPMorgan Chase & Co. increased its position in Radcom by 1,433.3% during the 4th quarter. JPMorgan Chase & Co. now owns 4,600 shares of the technology company's stock worth $57,000 after buying an additional 4,300 shares during the period. State of Tennessee Department of Treasury acquired a new stake in shares of Radcom during the fourth quarter worth $62,000. Prudential Financial Inc. acquired a new stake in shares of Radcom during the fourth quarter worth $183,000. Finally, Northern Trust Corp bought a new stake in shares of Radcom in the fourth quarter valued at about $269,000. 48.32% of the stock is owned by institutional investors.
Analyst Ratings Changes
RDCM has been the subject of several analyst reports. Needham & Company LLC lifted their price objective on shares of Radcom from $17.00 to $18.00 and gave the stock a "buy" rating in a research note on Thursday, May 15th. Wall Street Zen upgraded shares of Radcom from a "buy" rating to a "strong-buy" rating in a research report on Friday, May 16th.
Read Our Latest Stock Report on RDCM
Radcom Stock Up 1.1%
Shares of NASDAQ:RDCM traded up $0.15 during trading on Friday, reaching $13.73. 33,290 shares of the company traded hands, compared to its average volume of 57,793. The firm has a market capitalization of $214.93 million, a PE ratio of 25.42 and a beta of 0.73. Radcom Ltd. has a 52 week low of $9.08 and a 52 week high of $15.98. The company's 50 day moving average is $12.83 and its two-hundred day moving average is $12.48.
Radcom Company Profile
(
Free Report)
RADCOM Ltd. provides 5G ready cloud-native, network intelligence, and service assurance solutions for telecom operators or communication service providers (CSPs). It offers RADCOM ACE, including RADCOM Service Assurance, a cloud-native, 5G-ready, and virtualized service assurance solutions, which allows telecom operators to gain end-to-end network visibility and customer experience insights across all networks; RADCOM Network Visibility, a cloud-native network packet broker and filtering solution that allows CSPs to manage network traffic at scale across multiple cloud environments, and control the visibility layer to perform analysis of select datasets; and RADCOM Network Insights, a business intelligence solution that offers insights for multiple use cases enabled by data captured and correlated through RADCOM Network Visibility and RADCOM Service Assurance.
Read More

Before you consider Radcom, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Radcom wasn't on the list.
While Radcom currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.